Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 301–350 of 549 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02599662	Intraoperative Radiation Therapy for Resectable Pancreas Cancer(IORT)	unknown	Phase 1	12	Loyola UniversityOTHER	1	Jun 4, 2020	clinicaltrials
NCT04415385	The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma	unknown	Phase 2	48	Zhejiang Cancer HospitalOTHER	1	Jun 4, 2020	clinicaltrials